Innovative technology for better management of glaucoma
Multi-modal Health Information Technology Innovations for Precision Management of Glaucoma
This study is looking to help people with glaucoma by using smart technology to find those at risk of losing their vision quickly, so they can get better care and avoid expensive surgeries.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Diego NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project ID | NIH-10919171 on NIH RePORTER |
What this research studies
This research focuses on improving the management of glaucoma, a leading cause of irreversible blindness, by using advanced health information technology. It aims to identify individuals at high risk for developing glaucoma and those likely to experience rapid vision loss through a data-driven precision medicine approach. The study will consider patients' overall health, including systemic conditions like hypertension, and their adherence to prescribed treatments. By integrating various data sources, the research seeks to enhance patient outcomes and reduce the need for costly surgical interventions.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals at risk for glaucoma, particularly those with systemic conditions such as hypertension.
Not a fit: Patients who do not have glaucoma or are not at risk for developing the condition may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized treatment strategies for glaucoma patients, potentially preserving their vision.
How similar studies have performed: Preliminary studies have shown promise in using systemic data to predict glaucoma risk, indicating that this approach may be effective.
Where this research is happening
La Jolla, United States
- University of California, San Diego — La Jolla, United States (Active)
Researchers
- Principal investigator: Baxter, Sally Liu — University of California, San Diego
- Study coordinator: Baxter, Sally Liu
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.